» Articles » PMID: 11806999

Molecular Dissection of the Signaling and Costimulatory Functions of CD150 (SLAM): CD150/SAP Binding and CD150-mediated Costimulation

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Jan 25
PMID 11806999
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

CD150 signaling lymphocytic activation molecule (SLAM), a T/B/dendritic cell surface glycoprotein, is a costimulatory receptor involved in T-cell activation and is also a receptor for measles virus. CD150-induced signal transduction is controlled by SAP/SH2D1A, the gene that is aberrant in X-linked lymphoproliferative disease and familial hemophagocytic lymphohistiocytosis. This report shows that CD150 colocalizes with the T-cell receptor (TCR) following CD3 triggering in human peripheral blood T cells and is rapidly and reversibly tyrosine phosphorylated on TCR cross-linking. The Src-like kinases Lck and Fyn phosphorylate tyrosine residues in the cytoplasmic tail of CD150. The results demonstrate that the SAP protein has 2 modes of binding to CD150. Binding to the motif Thr-Ile-Tyr281Ala-Gln-Val occurs in a phosphotyrosine-independent fashion and to the motif Thr-Val-Tyr327Ala-Ser-Val in a phosphotyrosine-dependent manner. Within both SAP binding motifs the threonine residue at position -2 to tyrosine is essential to stabilize the interaction irrespective of tyrosine phosphorylation, a feature unique to the SAP SH2 domain. A leucine residue, Leu278, further stabilizes nonphospho binding of SAP to Tyr281 of CD150. SAP blocking of the tyrosine phosphatase SHP-2 occurs primarily on Tyr281 of CD150 because SHP-2 requires both Tyr281 and Tyr327 for binding to CD150, and SAP binds to nonphosphorylated Tyr281. CD150 exhibits lateral mobility, segregating into intercellular contacts. The lateral mobility and homophilic clustering of CD150 between neighboring cells is not dependent on SAP/CD150 interaction.

Citing Articles

Systemic inflammatory regulators and age-related macular degeneration: a bidirectional Mendelian randomization study.

Liu X, Cao Y, Wang Y, Kang L, Zhang G, Zhang J Front Genet. 2024; 15:1391999.

PMID: 39734575 PMC: 11671502. DOI: 10.3389/fgene.2024.1391999.


Modulation of Dietary Fatty Acids in an Open-Label Study Improves Psoriasis and Dampens the Inflammatory Activation Status.

Saalbach A, Seitz A, Kohlmann J, Kalweit L, Vogt L, Selig L Nutrients. 2023; 15(7).

PMID: 37049538 PMC: 10097201. DOI: 10.3390/nu15071698.


speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing.

Castellanos-Rueda R, Di Roberto R, Bieberich F, Schlatter F, Palianina D, Nguyen O Nat Commun. 2022; 13(1):6555.

PMID: 36323661 PMC: 9630321. DOI: 10.1038/s41467-022-34141-8.


SLAM Associated Protein Signaling in T Cells: Tilting the Balance Toward Autoimmunity.

Gartshteyn Y, Askanase A, Mor A Front Immunol. 2021; 12:654839.

PMID: 33936082 PMC: 8086963. DOI: 10.3389/fimmu.2021.654839.


Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases.

Magnusson L, Espes D, Casas R, Carlsson P Front Immunol. 2020; 11:1916.

PMID: 32983115 PMC: 7476208. DOI: 10.3389/fimmu.2020.01916.